UroCCR

Le Pr Jean-Christophe BERNHARD (coordinateur national) et le Pr Pierre BIGOT (coordinateur national-adjoint) du réseau @UroCCR sont ravis d’accueillir les participants de cette 7ème édition.

At #EAU26, during the @EAUYAUrology meeting, the Best Abstract by a YAU Group is presented by @GaelleMargue 🇫🇷Bordeaux Highlighting outstanding research and innovation from the next generation of academic urologists.

Thank you to everyone who attended today’s webinar 🙏🏻 A truly insightful session, with excellent updates shared by an outstanding faculty. Great content, great interaction, and a very engaged audience 👏👏

UROwebinar Alert Locally advanced renal cancer – Surgical challenges 📅 11 Nov 25 🕢 18:30 Top faculty from ESU, EAU & YAU will cover complex RCC surgery, caval thrombus management, and the role of neo/adjuvant therapy 🔗 Register via MyEAU @UrowebESU

@NYCRoboticTeam @EAUYAU_RenalCa 👏🏻 @NYCRoboticTeam and @EAUYAU_RenalCa Certainly a fantastic opportunity for collaborations with @uroccr which Database already counts 22,000+ kidney patients

Proud of the team for putting a lot of time and effort into this initiative. Thank you to our USA colleagues over the years and welcome to the @EAUYAU_RenalCa group! 20,000+ robotic kidney patients A lot to learn!

The Malouf Lab at IGBMC (Strasbourg, France) is recruiting a postdoctoral researcher to join a translational research program focused on rare and treatment-resistant kidney cancers. 🔗 Full details here: igbmc.fr/en/job-offers/… Let’s build something meaningful @SPBassociation

1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immunobiology: Can we use machine-learning approaches to classify RCC and predict response? @Cancer_Cell What drives exceptional response with immunotherapies? @NatureCancer How do specific immune populations, like NK cells, change in advanced disease? @ESMO_Open How does CD8+ T cell phenotype impact response to anti-PD1 treatment? @CD_AACR Why does chromophobe kidney cancer seemingly have lower responses to immune checkpoint inhibitors? @JCO_ASCO What are immunologically relevant antigen classes in RCC (specifically, ERVs)? @CellCellPress Can we therapeutically target tumor-specific antigens in kidney cancer? @Nature

@DrDanielHeng @oncodaily @ASCO @IMDConline @UCalgaryMed @AHS_media @OncoAlert 👏🏻👏🏻 @DrDanielHeng !

Thank you @oncodaily @ASCO #asco25 for this amazing honor. Research never stops. Thanks to everyone from the @IMDConline and collaborators. @UCalgaryMed @AHS_media @oncoalert

The best outcomes of kidney tumour resections are observed for patients treated at higher-volume hospitals. Is it time to change the @CUS_CLS_JEP rules for CZ? #uroczech pubmed.ncbi.nlm.nih.gov/40210551/

Productive first meeting of the new YAU RCC team! Projects assigned, ideas flowing, collaborations set in motion💡🤝🏻 Ready to tackle the key challenges in RCC research — together 💪🏻 @eau_yuo @Uroweb

7 robotic surgical platforms. Live cases. The best in robotic urology. Welcome to ERUS25! 📍 London, 10-12 September, 2025 📌Registration & abstract submission now open! 🚀 Live surgery, case discussions, industry sessions and more! 🔗 Join us: erus25.org

🤖Can AR enhance robotic surgery for complex urology surgery? 🎯 Case @#EAU25: ✅ Radical nephrectomy + IVC thrombectomy ✅ 3D model overlay + automated tracking ✅ Improved view of thrombus & lumbar veins 🎥 youtu.be/6dvF_1cN-C8 #Urology #RoboticSurgery #AR @uroccr @Uroweb

🔬 #EAU25 – Jour 3 : Les faits marquants ! 🔬 💡 Rein : 🇫🇷 La France brille au #UroCCR avec 13 abstracts ! 📊 Dépistage du CCR : acceptabilité élevée (96,1 % sans regret), coût-efficace et 1/50 cancers détectés. 🛠 Lithiase : 💨 Aspiration > mesure du volume des fragments ? Débat relancé ! 🆕 Glitz et CVAC en test : révolution ou complications ? 🔬 Prostate : 🚫 TRANSLATE : fin actée de la voie transrectale pour les biopsies. 🎯 OPTIMUM : microUS ≈ IRM pour détecter les CaP cliniquement significatifs. 📉 ARNEO : ajout d’apalutamide en néoadjuvant ? Pas d’impact majeur. 🔥 Urothélial : 🦠 ctDNA pré-cystectomie : biomarqueur clé de la récidive ! 🔪 Curage ganglionnaire maximal essentiel pour le pronostic. Robot vs ouvert = pas de différence. 🦠 Infectiologie : 💊 APPEAL trial : prophylaxie antibiotique en ESWL ? Cipro ↓ urosepsis (0 vs 1,2 %, p=0.003), mais pas d’impact sur ITU symptomatiques. ➡️ #Urology #MedTwitter @FUTUR_AFU @Uroweb @MRoupret

Day 3 at #EAU25 was all about kidney cancer: 🩺 screening, surgical techniques, 🤖 technological innovation, 🧪 biomarkers, and 🧩 complex cases. A deep dive into challenges and progress! Now time to gather with friends and enjoy the night in Madrid! @Uroweb @AFUrologie @uroccr

Very grateful for the opportunity to present results of multicentric CAVORISK study (UroCCR 174) at #EAU2025 ! Left-sided renal tumors with IVC thrombus are associated to an increase risk of hemodialysis after surgery. @AlexIngels @uroccr @afufuro @AFUrologie

Félicitations @d_paillusson pour cette très belle présention à EAU congress de Madrid @uroccr @Uroweb @CHUnantes @maperrouinverbe @AFUrologie @BranchereauJu

Day 2 at #EAU25 🤖Presented AR-guided robot-assisted nephrectomy + IVC thrombectomy (@CHUBordeaux) 🧠“Urology made simple” during YUOR Day—great way to clarify complex topics 💊Cabozantinib remains effective post-IO (Controversies in GU cancer) Great science, great sessions!

That’s a wrap for Day 1 at #EAU25! Great discussions, innovations, and controversies in urology. More to come! @uroccr @Uroweb @afufuro @FUTUR_AFU @AFUrologie

In the US, over 600,000 people live with kidney cancer and thousands of new cases will be diagnosed this year. Thanks to breakthrough treatments and research, hope is stronger than ever! #KidneyCancerAwarenessMonth #OrangeUp 🧡 kidneycancer.org/event/kidney-c…

@SpiessPhilippe Congrats @SpiessPhilippe !

Thanks so much Karen! This really means alot coming from a great leader like you most notably in your inaugural year as our incredible physician in chief! 😊🎉

1/5 Sharing our @CCR_AACR work establishing serum CA-125 as a biomarker for #RenalMedullaryCarcinoma. This is now the first cancer-associated blood biomarker to become standard of care and used globally for a #kidneycancer : #MsaouelLab" target="_blank" rel="nofollow noopener">aacrjournals.org/clincancerres/… @TheVFoundation @renalmedullary